22NW, LP 对 LFCR 的持仓历史
LIFECORE BIOMEDICAL INC · 医疗保健
22NW, LP 在 Q3 2026 的 13F 申报中披露持有 LFCR(LIFECORE BIOMEDICAL INC)1,254 股,市值约 US$8K,约占其申报组合的 0.01%,在其申报持仓中市值排名第 15 位。 22NW, LP 最近 13 个申报季度中有 13 个季度披露了 LFCR 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
22NW, LP 对 LFCR 的持仓演变
22NW, LP 于 Q3 2023 首次披露 LFCR 持仓:1,755,161 股(约 US$13.3M)。 该持仓在 Q4 2024 达到峰值 1,755,161 股,市值约 US$31.1M。 在 13 次申报中,22NW, LP 0 次增持、2 次减持、10 次保持不变。 最近一期申报(Q3 2026)显示持股 1,254 股、市值约 US$8K。 持仓曾出现大幅变动:Q2 2025 减持约 85% (随后一个季度股价下跌 9%)、Q3 2025 减持约 100% (随后一个季度股价上涨 11%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 1.76M | $13.25M | 新进 |
| Q4 2023 | 1.76M | $10.86M | 持有 |
| Q1 2024 | 1.76M | $9.32M | 持有 |
| Q2 2024 | 1.76M | $24.00M | 持有 |
| Q3 2024 | 1.76M | $23.65M | 持有 |
| Q4 2024 | 1.76M | $31.15M | 持有 |
| Q1 2025 | 1.76M | $29.82M | 持有 |
| Q2 2025 | 264.18K | $22.63M | 减持 |
| Q3 2025 | 1.25K | $20.15M | 减持 |
| Q4 2025 | 1.25K | $23.03M | 持有 |
| Q1 2026 | 1.25K | $18.87M | 持有 |
| Q2 2026 | 1.25K | $6.22K | 持有 |
| Q3 2026 | 1.25K | $8.25K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 LFCR 与 13F 数据
LFCR(LIFECORE BIOMEDICAL INC)属于医疗保健行业。我们追踪的基金中还有 21 只申报持有 LFCR,申报仓位最大的包括:WYNNEFIELD CAPITAL INC (US$24.7M), Legion Partners Asset Management, LLC (US$23.4M), Greenhaven Road Investment Management, L.P. (US$18.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 LFCR 的基金
- WYNNEFIELD CAPITAL INC 4.70M 股 · $24.69M · Q2 2026
- Legion Partners Asset Management, LLC 4.46M 股 · $23.42M · Q2 2026
- Greenhaven Road Investment Management, L.P. 2.87M 股 · $18.88M · Q3 2026
- 325 CAPITAL LLC 2.90M 股 · $15.20M · Q2 2026
- DCF Advisers, LLC 376.50K 股 · $2.48M · Q3 2026
- WITTENBERG INVESTMENT MANAGEMENT, INC. 314.01K 股 · $1.65M · Q2 2026
常见问题
How long has 22NW, LP held LFCR?
22NW, LP has disclosed LFCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is 22NW, LP's current position in LFCR?
As of Q3 2026, 22NW, LP holds 1.25K shares of LFCR (LIFECORE BIOMEDICAL INC), valued at $8.25K, representing 0.01% of its reported portfolio and ranking #15.
Has 22NW, LP been buying or selling LFCR?
In the latest 13F filing (Q3 2026), 22NW, LP held unchanged its position in LFCR. The position peaked in Q4 2024 at 1.76M shares.
Which other funds hold LFCR?
Other major institutional holders of LFCR include WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, Greenhaven Road Investment Management, L.P., among 21 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.